Associated Papers
Validation of an NGS Panel Designed for Detection of Actionable Mutations in Tumors Common in Latin America.
Salvo M et al.
Journal of Personalized Medicine, 2021
Development and Validation of a 34-Gene Inherited Cancer Predisposition Panel Using Next-Generation Sequencing.
Rosenthal SH et al.
Biomed Research International, 2020
Exome sequencing covers >98% of mutations identified on targeted next generation sequencing panels.
LaDuca H et al.
Plos One, 2017
28152038 (PubMed )
Supplement: pone.0170843.s003.xlsx › S3_Table
Targeted Resequencing of 30 Genes Improves the Detection of Deleterious Mutations in South Indian Women with Breast and/or Ovarian Cancers.
Rajkumar T et al.
Asian Pacific Journal of Cancer Prevention : Apjcp, 2015
Select a paper to view details